The previous page is sending you to https://www.oncotarget.com/news/pr/quizartinib-a-selective-flt3-inhibitor-maintains-antileukemic-activity-in-preclinical-models-of-ras-mediated-midostaurin-resistant-acute-myeloid-leukemia-cells/.

 If you do not want to visit that page, you can return to the previous page.